admit-therapeutics.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: * Allow: / Disallow: | ||
Meta Tags
| Title | ADmit THERAPEUTICS - test for an early AD detection. Alzheimer’s |
| Description | DETECTION IN CLINICAL ADmit THERAPEUTICS - test for an early AD detection. Alzheimer’s disease. DETECTION IN CLINICAL PRACTICE. ADmit Therapeutics, S.L. is a spin-off from the Bellvitge Biomedical Research Institute (IDIBELL), and focused on the development and |
| Keywords | ADmit Therapeutics, Alzheimer’s disease, AD, early AD detection, clinical, practice, Bellvitge, Biomedical Research |
Server Information
| WebSite | |
| Host IP | 146.59.172.78 |
| Location | Norway |
Related Websites
| Site | Rank |
More to Explore
admit-therapeutics.com Valuation
|
US$389,008
Last updated: 2023-05-18 19:58:48
admit-therapeutics.com has Semrush global rank of 27,208,481. admit-therapeutics.com has an estimated worth of US$ 389,008, based on its estimated Ads revenue. admit-therapeutics.com receives approximately 44,886 unique visitors each day. Its web server is located in Norway, with IP address 146.59.172.78. According to SiteAdvisor, admit-therapeutics.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$389,008 |
| Daily Ads Revenue | US$360 |
| Monthly Ads Revenue | US$10,773 |
| Yearly Ads Revenue | US$129,271 |
| Daily Unique Visitors | 2,993 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| admit-therapeutics.com. | A | 86400 | IP: 146.59.172.78 |
| admit-therapeutics.com. | NS | 21600 | NS Record: ns2-ovh.galileu-o.net. |
| admit-therapeutics.com. | NS | 21600 | NS Record: ns1-ovh.galileu-o.net. |
| admit-therapeutics.com. | MX | 21600 | MX Record: 5 alt2.aspmx.l.google.com. |
| admit-therapeutics.com. | MX | 21600 | MX Record: 10 alt3.aspmx.l.google.com. |
| admit-therapeutics.com. | MX | 21600 | MX Record: 5 alt1.aspmx.l.google.com. |
| admit-therapeutics.com. | MX | 21600 | MX Record: 10 alt4.aspmx.l.google.com. |
| admit-therapeutics.com. | MX | 21600 | MX Record: 1 aspmx.l.google.com. |
| admit-therapeutics.com. | TXT | 86400 | TXT Record: v=spf1 ip4:146.59.172.78 ip4:52.17.82.87 +a +mx +include:_spf.google.com ~all |
HtmlToTextCheckTime:2023-05-18 19:58:48
| ADmit Technology Team Partners News Contact Conditions of use Privacy policy for social networks Cookies policy Accionistas en | es test for an early AD detection Alzheimer’s disease Accionistas en es ADmit Technology Team Partners News Contact test for an early AD detection Alzheimer’s disease DETECTION IN CLINICAL PRACTICE ADmit Therapeutics, S.L. is a spin-off from the Bellvitge Biomedical Research Institute (IDIBELL), and focused on the development and commercialization of a novel Alzheimer’s disease (AD) early detection technology. Rigurosity Our clinical studies are rigurously analyzed Efficiency We optimize our own resources Agility We adopt agile decissions TEAMWORK AND INNOVATION Our diagnostic test represents the determination of biomarkers non-related with β-amyloid nor tau. Our findings may become a pool of biomarkers very useful for the detection of patients at early stages of AD. News ADmit Therapeutics announces a new investment of up to $1,886,058 from the Diagnostics |
HTTP Headers
HTTP/1.1 301 Moved Permanently Server: nginx Date: Wed, 20 Jul 2022 08:32:02 GMT Content-Type: text/html Content-Length: 162 Connection: keep-alive Location: https://admit-therapeutics.com/ HTTP/2 301 server: nginx date: Wed, 20 Jul 2022 08:32:03 GMT content-type: text/html; charset=iso-8859-1 location: http://www.admit-therapeutics.com/ x-powered-by: PleskLin HTTP/1.1 301 Moved Permanently Server: nginx Date: Wed, 20 Jul 2022 08:32:03 GMT Content-Type: text/html Content-Length: 162 Connection: keep-alive Location: https://www.admit-therapeutics.com/ HTTP/2 301 server: nginx date: Wed, 20 Jul 2022 08:32:03 GMT content-type: text/html; charset=iso-8859-1 location: https://www.admit-therapeutics.com/en x-powered-by: PleskLin |
admit-therapeutics.com Whois Information
Domain Name: ADMIT-THERAPEUTICS.COM Registry Domain ID: 2199025819_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.enom.com Registrar URL: http://www.enomdomains.com Updated Date: 2021-01-21T20:04:47Z Creation Date: 2017-12-12T09:31:47Z Registry Expiry Date: 2023-12-12T09:31:47Z Registrar: eNom, LLC Registrar IANA ID: 48 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS1-OVH.GALILEU-O.NET Name Server: NS2-OVH.GALILEU-O.NET DNSSEC: unsigned >>> Last update of whois database: 2022-07-20T08:26:34Z <<< |